The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

Background: The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial aimed to determine whether or not oral Δ9-tetrahydrocannabinol (Δ9-THC) slowed the course of progressive multiple sclerosis (MS); evaluate safety of cannabinoid administration; and, improve methods for testing tr...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Susan Ball, Jane Vickery, Jeremy Hobart, Dave Wright, Colin Green, James Shearer, Andrew Nunn, Mayam Gomez Cano, David MacManus, David Miller, Shahrukh Mallik, John Zajicek
פורמט: Artigo
שפה:Inglês
יצא לאור: NIHR Journals Library 2015-02-01
סדרה:Health Technology Assessment
נושאים:
multiple sclerosis
cannabinoids
dronabinol
magnetic resonance imaging
randomised controlled trial
cupid trial
גישה מקוונת:https://doi.org/10.3310/hta19120
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים